Pages that link to "Q79451455"
Jump to navigation
Jump to search
The following pages link to Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling (Q79451455):
Displaying 50 items.
- Insight into Pulmonary Arterial Hypertension Associated with Congenital Heart Disease (PAH-CHD): Classification and Pharmacological Management from a Pediatric Cardiological Point of View (Q26749283) (← links)
- Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis (Q27311601) (← links)
- Inhibition of phosphatidylinositol 3-kinase/Akt signaling attenuates hypoxia-induced pulmonary artery remodeling and suppresses CREB depletion in arterial smooth muscle cells (Q28581058) (← links)
- The PPARbeta/delta agonist GW0742 relaxes pulmonary vessels and limits right heart hypertrophy in rats with hypoxia-induced pulmonary hypertension (Q33538017) (← links)
- PPARγ attenuates hypoxia-induced hypertrophic transcriptional pathways in the heart (Q33738569) (← links)
- Role of vascular endothelial growth factor signaling in Schistosoma-induced experimental pulmonary hypertension (Q33806046) (← links)
- Time-dependent PPARγ Modulation of HIF-1α Signaling in Hypoxic Pulmonary Artery Smooth Muscle Cells (Q33831356) (← links)
- Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies (Q33849207) (← links)
- Inhaled PLGA particles of prostaglandin E₁ ameliorate symptoms and progression of pulmonary hypertension at a reduced dosing frequency (Q33895831) (← links)
- Targeting mitochondria to restore failed adaptation to exercise in diabetes. (Q33919949) (← links)
- PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B. (Q34212735) (← links)
- The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation (Q34294854) (← links)
- Dysregulation of claudin-5 in HIV-induced interstitial pneumonitis and lung vascular injury. Protective role of peroxisome proliferator-activated receptor-γ. (Q34480264) (← links)
- Is Peroxisome Proliferator‐Activated Receptor Gamma (PPARγ) a Therapeutic Target for the Treatment of Pulmonary Hypertension? (Q34897476) (← links)
- New perspectives for the treatment of pulmonary hypertension (Q34903204) (← links)
- Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats (Q35014605) (← links)
- Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension (Q35040811) (← links)
- Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone (Q35087009) (← links)
- Peroxisome proliferator-activated receptor γ inhibits pulmonary hypertension targeting store-operated calcium entry (Q35102314) (← links)
- Effects of chrysin (5,7-dihydroxyflavone) on vascular remodeling in hypoxia-induced pulmonary hypertension in rats (Q35123675) (← links)
- Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension. (Q35219809) (← links)
- Estrogen receptor beta inhibits transcriptional activity of hypoxia inducible factor-1 through the downregulation of arylhydrocarbon receptor nuclear translocator (Q35558975) (← links)
- Hypoxia induces downregulation of PPAR-γ in isolated pulmonary arterial smooth muscle cells and in rat lung via transforming growth factor-β signaling (Q35601455) (← links)
- Eosinophils are necessary for pulmonary arterial remodeling in a mouse model of eosinophilic inflammation-induced pulmonary hypertension (Q35601475) (← links)
- PPARγ Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21. (Q35711530) (← links)
- The Role of PPARgamma in pulmonary vascular disease (Q35794254) (← links)
- Activation of peroxisome proliferator-activated receptor γ ameliorates monocrotaline-induced pulmonary arterial hypertension in rats (Q35803453) (← links)
- Airway epithelial cell PPARγ modulates cigarette smoke-induced chemokine expression and emphysema susceptibility in mice. (Q35916876) (← links)
- Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension (Q35994471) (← links)
- Obesity and pulmonary hypertension: a review of pathophysiologic mechanisms (Q36228769) (← links)
- Pulmonary arterial remodeling induced by a Th2 immune response (Q36502869) (← links)
- MAP kinase kinase kinase-2 (MEKK2) regulates hypertrophic remodeling of the right ventricle in hypoxia-induced pulmonary hypertension (Q36528033) (← links)
- Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling. (Q36549041) (← links)
- Mutual inhibitory mechanisms between PPARγ and Hif-1α: implication in pulmonary hypertension. (Q36728374) (← links)
- Molecular pathogenesis of pulmonary arterial hypertension (Q36736065) (← links)
- Relaxation of human pulmonary arteries by PPARγ agonists. (Q36755896) (← links)
- Transforming growth factor-beta signaling mediates hypoxia-induced pulmonary arterial remodeling and inhibition of alveolar development in newborn mouse lung (Q36808016) (← links)
- Antagonism of stem cell factor/c-kit signaling attenuates neonatal chronic hypoxia-induced pulmonary vascular remodeling. (Q36813761) (← links)
- Role of matrix metalloproteinase-2 in newborn mouse lungs under hypoxic conditions (Q36840084) (← links)
- Proline-rich tyrosine kinase 2 downregulates peroxisome proliferator-activated receptor gamma to promote hypoxia-induced pulmonary artery smooth muscle cell proliferation (Q36908849) (← links)
- Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension (Q36964914) (← links)
- Signal transduction in the development of pulmonary arterial hypertension (Q37133785) (← links)
- Sodium tanshinone IIA sulfonate inhibits hypoxia-induced enhancement of SOCE in pulmonary arterial smooth muscle cells via the PKG-PPAR-γ signaling axis (Q37139389) (← links)
- Peroxisome Proliferator-Activated Receptor-gamma Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer. (Q37157524) (← links)
- Sildenafil inhibits hypoxia-induced transient receptor potential canonical protein expression in pulmonary arterial smooth muscle via cGMP-PKG-PPARγ axis (Q37297884) (← links)
- Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension. (Q37434434) (← links)
- Contributions of adipose tissue architectural and tensile properties toward defining healthy and unhealthy obesity. (Q37575442) (← links)
- Peroxisome proliferator activated receptor-γ-Rho-kinase interactions contribute to vascular remodeling after chronic intrauterine pulmonary hypertension (Q37576061) (← links)
- Hyperoxia synergizes with mutant bone morphogenic protein receptor 2 to cause metabolic stress, oxidant injury, and pulmonary hypertension. (Q37596437) (← links)
- Rosiglitazone Attenuated Endothelin-1-Induced Vasoconstriction of Pulmonary Arteries in the Rat Model of Pulmonary Arterial Hypertension via Differential Regulation of ET-1 Receptors (Q37632333) (← links)